North America Methotrexate Injection Market is expected to grow with a CAGR of 6.0% in the forecast period of 2022 to 2029. The years considered for the study are as mentioned below.
North America methotrexate injection market is a highly consolidated market. The market has witnessed increased strategic developments owing to a favourable market scenario.
The major players dealing in North America methotrexate injection market are introducing a strong range of product portfolios. This helped companies to maximize sales with an enhanced product portfolio.
Pfizer Inc. is dominating player in North America methotrexate injection market. The other key players existing in the market include Antares Pharma, Inc., Fresenius Kabi USA, Medexus Pharmaceuticals, Inc., Viatris Inc., Sandoz AG (A Subsidiary of Novartis AG), Teva Pharmaceuticals USA, Inc., Accord BioPharma, Hikma Pharmaceuticals PLC, Cumberland Pharmaceuticals Inc., PV Pharma among others.
Pfizer Inc. was founded in 1849 and is headquartered in New York, U.S. The company focuses on providing standard for quality, safety and value in the discovery, development and manufacturing of health care products, including innovative medicines and vaccines. The company offers the product in categories including methotrexate, among others, in which market-focused category fall under methotrexate. The company is taking strategic initiatives to increase its portfolio.
The company has a global presence in North America, Europe, Middle East and Africa, Asia-Pacific, and South America. The company has many subsidiaries, such as Pfizer Animal Health B.V.(Netherlands), Pfizer Asia International B.V. (Netherlands), Pfizer Australia Superannuation Pty Ltd (Australia), Pfizer Dominicana, S.A. (Dominican Republic) and Pfizer Egypt S.A.E. (Egypt) among others.
Antares Pharma, Inc.
Antares Pharma Inc. is headquartered in New Jersey, U.S. The company focuses on pharmaceutical and medical devices to develop innovative products that address needs in underserved therapeutic areas. The company offers OTREXUPI products.
The company has a presence in the Americas. The company has many subsidiaries, such as Antares Pharma AG (Switzerland) and Antares Pharma IPL AG (Switzerland).
Fresenius Kabi USA
Fresenius Kabi USA was founded in 1912 and is headquartered in Illinois, U.S. The company is a global healthcare company specialising in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. The company offers product categories, including Pharmaceuticals, Medical Devices, under which the market focused category falls under Pharmaceuticals.
The company has global presence in the Asia-Pacific, Europe, Middle East and Africa, South America, and North America.